Anzeige
❌
Mehr »
Montag, 16.11.2026 - Börsentäglich über 12.000 News
Pelican AI: +34,75% in Frankfurt! Ist das erst der Anfang einer großen Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Stocks Down Under

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrApplied Materials (NASDAQ:AMAT) Stock Rises After Earnings Beat: AI Drives 53% Revenue Growth
DoWhy Is Super Micro (NASDAQ:SMCI) Stock Crashing 11%? DOJ Probes China Chip Smuggling Allegations
DoWhat Are Some Online Brokers for Trading Forex and CFDs? Five Platforms Australian Traders Use
DoArdelyx (NDQ:ARDX): Have Investors Lost Sight Of The Long-Term Story?
DoImmunityBio (NDQ:IBRX): The Next Keytruda Or The Next Niche Oncology Drug? Investors Are Excited!
DoAMD and Broadcom Rally as Nvidia Falls: Are AI Chip Rivals Gaining Ground?
DoIs Xero (ASX:XRO) a Long-Term Buy After Its H1 FY27 Results?
DoClarity Pharmaceuticals (ASX:CU6): Twice the lesions, half the wait. Why the FDA fast tracked CU6's copper scan
DoXero (ASX:XRO) Upgrades Guidance and Announces A$1bn Share Buyback
DoAristocrat (ASX:ALL) The Pokies Business Is Booming. Can Its Online Division Catch Up?
DoOrica (ASX:ORI) clocks A$1.06bn EBIT as Digital reshapes the mix
DoCoreWeave (NASDAQ:CRWV) 168% Revenue Growth Reignites AI Trade Despite Debt Risk
DoGrainCorp (ASX:GNC) The Worst May Be Over as Harvest Volumes Start Rebounding
DoG8 Education (ASX:GEM) A 160% Premium Takeover Offer Is on the Table. Is It Enough?
DoPfizer (NYSE:PFE) Is Getting $1.5bn From Blackstone To Fund Its GLP-1 Ambitions
DoD-Wave Quantum (NDQ:QBTS): This Quantum Computing Play Grew Revenues By 20%, But Losses Are Growing Too
MiCoreWeave flexes, Nebius tags along … the Neocloud party is back on
MiLennar Corporation (NYSE: LEN) and NVR (NYSE: NVR) Fall Amidst US Inflation Concerns
MiNvidia's Jensen Problem Could Cost a Lot More Than a CEO
MiBioMarin Pharmaceutical (NDQ:BMRN): The Market Sees A Mature Slow-Growth Biotech, But Is It Missing The Next Growth Leg?
MiReplimune (NDQ:REPL): Is TUDRIQEV Just A Melanoma Drug, Or The First Validation Of An Entirely New Cancer Treatment Platform?
MiAmplia Therapeutics (ASX:ATX) had outstanding Phase 2 data for narmafotinib in pancreatic cancer!
MiPEXA Group (ASX:PXA) FY27 Margins Are Sliding. Is the Housing Cycle Now the Bigger Risk?
MiNvidia (NASDAQ:NVDA) Stock Crashes 5.5% as $7.5 Billion China Chip Claims Trigger Fresh Scrutiny
MiAdairs (ASX:ADH) One Weak Division Is Dragging Down the Whole Group